Chemo Side Effects Need More Focus in Drug Review: FDA Official

September 26, 2018

Cancer patients could have a better idea of how newer therapies affect their daily lives as the Food and Drug Administration’s (FDA) oncology chief wants to address underreporting of the side effects.

Related Stories